A39.5 Meningococcal heart disease

Name of the Condition

• Meningococcal heart disease

Summary

Meningococcal heart disease is a rare but serious complication of Neisseria meningitidis infection, involving inflammation or damage to the heart structures. It may occur as part of systemic meningococcal disease and can present with cardiac symptoms or findings. Prompt recognition and treatment are essential to manage cardiac involvement and prevent further complications.

Causes

Meningococcal heart disease is caused by Neisseria meningitidis, a bacterium that can spread through respiratory droplets or direct contact with infected secretions. The infection may lead to myocarditis (inflammation of the heart muscle), pericarditis (inflammation of the pericardium), or endocarditis (infection of the heart valves), typically as a result of bacteremia or septicemia.

Risk Factors

• Meningococcal infection (especially with certain serogroups).
• Underlying immunocompromised states or asplenia.
• Lack of vaccination against meningococcal disease.
• Close contact with an infected individual.
• Severe or prolonged meningococcal septicemia.

Symptoms

• Chest pain or discomfort.
• Shortness of breath.
• Palpitations or irregular heartbeat.
• Fatigue or weakness.
• Fever (if active infection persists).
• Signs of heart failure (e.g., swelling in legs, fluid retention).

Diagnosis

Diagnosis involves clinical evaluation, cardiac imaging (e.g., echocardiogram), and laboratory testing. Blood cultures may identify Neisseria meningitidis, while cardiac biomarkers (e.g., troponin) can indicate myocardial injury. Imaging helps assess structural changes or inflammation in the heart.

Treatment Options

Treatment focuses on eradicating the underlying meningococcal infection with appropriate antibiotics (e.g., ceftriaxone, penicillin). Supportive care may include medications to manage heart function (e.g., beta-blockers, diuretics) or address complications like heart failure. Close monitoring of cardiac status is critical.

Prognosis and Follow-Up

Prognosis depends on the severity of cardiac involvement and timely treatment. Early intervention improves outcomes, but severe cases may lead to long-term cardiac damage. Follow-up with a cardiologist is recommended to monitor heart function and manage any residual issues.

Complications

• Chronic myocarditis or pericarditis.
• Heart failure or reduced cardiac function.
• Arrhythmias (irregular heart rhythms).
• Valve damage or endocarditis.
• Recurrent infection if not fully treated.

Lifestyle & Prevention

• Maintain up-to-date meningococcal vaccinations.
• Avoid close contact with infected individuals during outbreaks.
• Practice good hygiene (e.g., handwashing) to reduce transmission risk.
• Seek prompt medical care for suspected meningococcal symptoms.

When to Seek Professional Help

Seek immediate medical attention if you experience chest pain, severe shortness of breath, palpitations, or signs of infection (e.g., high fever, rash) after potential exposure to Neisseria meningitidis.

Tips for Medical Coders

Document the presence of cardiac involvement (e.g., myocarditis, pericarditis) and its relationship to meningococcal infection. Ensure clinical correlation with lab results or imaging to support the diagnosis. Code A39.5 is specific to meningococcal heart disease and should not be used for non-cardiac complications of meningococcal infection.